Latest coronavirus news

  • New environment-friendly shield could offer better protection during dental surgery 17 January 2022 Dental patients and practitioners could be better protected from COVID-19 and other airborne viruses and bacteria thanks to the development of a new environment-friendly shield by a multidisciplinary team from the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW). The shield could also increase the number of patients seen by dentists and help reduce procedure wait times.
  • Research reveals 'ugly truth' faced by doctors responding to COVID-19 on the frontline 13 December 2021 Frontline healthcare workers say they are angry at being treated as 'COVID cannon fodder, not COVID heroes' after responding to the virus for nearly two years and working at full capacity, reveal the findings of new research.
  • Bristol’s pioneering COVID-19 research prompts French Embassy visit 10 December 2021 Representatives from the French Embassy visited University labs today [10 December] to see some of the innovative COVID-19 research being undertaken at Bristol, including work on ADDomer™, a thermostable vaccine platform being developed by Bristol scientists to combat emerging infectious diseases.
  • Early warning signals could help monitor disease outbreaks 8 December 2021 New research suggests early warning signals (EWSs) could help in the monitoring of disease outbreaks, such as COVID-19. The study, led by the University of Bristol, found warnings could be detected weeks earlier than any rapid increase in cases. The findings could help governments and policy makers improve the accuracy of their decisions and allow timely interventions if needed.
  • Eating disorder symptoms and self-harm linked to higher levels of depression and anxiety during COVID-19 pandemic 7 December 2021 Young adults who have previously experienced self-harm or eating disorders reported higher levels of depression and anxiety during the pandemic, even when restrictions had eased, according to new research.
  • Child deaths during pandemic lowest on record for England 7 December 2021 The number of children in England who died fell to 3,067 between April 2020 – March 2021. This is 356 fewer deaths than were recorded in the preceding 12 months (April 2019 – March 2020), and likely represents the lowest level of child mortality on record, according to a new study by researchers at the Universities of Bristol and Cardiff and published today [7 December] in Archives of Disease in Childhood.
  • COVID-19 studies should record women’s menstrual changes, recommend researchers 2 December 2021 Large scale COVID-19 studies and clinical trials should collect data on menstrual changes, according to new research which evaluated current evidence. The findings, published in the International Journal of Epidemiology and led by University of Bristol researchers, say there is an important public health imperative for accurate scientific investigation of menstrual changes in relation to the COVID-19 pandemic.
  • Study aims to understand why COVID-19 vaccines can lead to very rare blood clotting with low platelets 30 November 2021 A group of 11 institutions, led by the University of Liverpool and including the University of Bristol, is seeking to understand the very rare, but very serious, condition of blood clotting with low platelets in the general population, in COVID-19 infection, and potentially following vaccination.
  • New study suggests asymptomatic testing and vaccination are critical for controlling COVID-19 at universities 25 November 2021 Reducing the transmission of COVID-19 in universities is heavily dependent on vaccination and asymptomatic testing uptake, new research by academics at the University of Bristol has found.
  • School staff not at higher risk of death from COVID-19 than other occupations, study finds 24 November 2021 Primary and secondary school staff were not at greater risk of death from COVID-19 in 2020 compared to other professions in England and Wales, new research has found. The study, by researchers at the University of Bristol, analysed data from the Office for National Statistics (ONS) national death register for school staff and working adults aged between 20- to 64-years-old.
  • Non-invasive breathing support for COVID-19 patients isn’t linked to heightened infection risk 4 November 2021 The use of non-invasive breathing support, commonly known as CPAP or HFNO, to treat moderate to severe COVID-19 infection, isn’t linked to a heightened infection risk, as currently thought, suggest two new studies which included work led by University of Bristol researchers. The findings and a linked editorial are published today [4 November] in Thorax .
  • Can portable air filters prevent respiratory infections and COVID-19 in care homes? 21 October 2021 A major new randomised controlled trial will investigate the effectiveness of air filtration systems in preventing respiratory infections (such as coughs, colds and flu) and COVID-19 among care home residents in England. The AFRI-c (Air Filters to Prevent Respiratory Infections including COVID-19 in Care Homes) study, which received funding from the National Institute for Health Research (NIHR), is led by researchers at the University of Bristol.
  • Collaborative COVID-19 lockdown effort delivers major boost for vaccine innovation in Bristol 7 October 2021 Faster vaccine development could be a step closer thanks to £4 million investment to Imophoron Ltd, a Bristol University biotech start-up developing a novel, next generation rapid-response vaccine platform called ADDomer™. Imophoron will use the investment to bring ADDomer vaccines to clinical stage, initially targeting three viruses, RSV (respiratory syncytial virus), COVID-19, and mosquito-borne Chikungunya.
  • It is safe for people to be vaccinated against COVID-19 and influenza at the same time, study shows 30 September 2021 Research has found that it is safe for people to receive a flu vaccine at the same time as a COVID-19 vaccine. Reported side effects were mainly mild to moderate, and there were no negative impacts on the immune response produced by either vaccine when both were given on the same day, in opposite arms.
  • Race against the virus: the Oxford AstraZeneca COVID-19 vaccine journey 28 September 2021 In late December 2019, a cluster of unusual pneumonia cases - now known to be the first human cases of COVID-19 - were reported in Wuhan, China. Thanks to the quick action of an Oxford scientist and her team, work on the response to the new virus began. Members of the public have the opportunity to hear the story of the Oxford AstraZeneca COVID-19 vaccine at a free online event next month.
  • Major advance in race for SARS-CoV-2 inhibitor drugs 20 September 2021 A new advance towards the development of drugs specifically designed to inhibit a key SARS-CoV-2 enzyme is reported in the Royal Society of Chemistry's leading journal, Chemical Science. The international team, led by scientists from the Universities of Oxford and Bristol, has designed new peptide molecules and shown that they block (inhibit) the virus’s main protease [Mpro] - a prominent SARS-CoV-2 drug target.
  • During the pandemic two thirds of bereaved people report experiencing social isolation and loneliness 14 September 2021 New research shows impact of grief during the pandemic as two thirds of bereaved people report experiencing social isolation and loneliness. Those bereaved due to COVID-19 were also less likely to be involved in care decisions and be well supported by healthcare professionals after the death of their loved one.
  • COVID-19 vaccine efficacy does not support boosters for general population, expert review concludes 13 September 2021 An expert review by an international group of scientists, including the World Health Organisation (WHO), Food and Drug Administration (FDA) and the University of Bristol, concludes that, even for the Delta variant, vaccine efficacy against severe COVID is so high that booster doses for the general population are not appropriate at this stage in the pandemic.
  • SARS-CoV-2 transmission model suggests primary school infection could be greater this autumn than in 2020 13 September 2021 The SARS-CoV-2 epidemic has already had a major impact on children's education, with schools having been required to implement infection control measures that have led to long periods of absence and classroom closures. With the new school year underway, risk modelling specialists at the University of Bristol have developed a new epidemiological model for SARS-CoV-2 transmission that forecasts primary school infection outbreaks could be more frequent and possibly substantially larger this autumn than in 2020, due to the more transmissive and infectious Delta variant and projected increase in community infection.
  • New option for how people with Covid-19 are cared for on NHS wards 30 August 2021 A new protocol for prone positioning — a technique commonly used to treat COVID-19 patients in respiratory distress by turning them on to their front to increase oxygen flow to the lungs, is published in the Journal of Frailty and Aging. Researchers from the University of Bristol in collaboration with clinicians at the Royal United Hospital in Bath, conducted a literature review of the manoeuvre to develop a standard protocol for the adjuvant treatment that can be used for COVID-19 patients at high risk of dying being treated in normal hospital wards.
Years iterator
Edit this page